Submit Your Questions for the January 12 Virtual Town Hall for SARS-CoV-2 Test Developers

U.S. Food and Drug Administration sent this bulletin at 01/05/2022 10:10 AM EST

If your email program has trouble displaying this email, view as a webpage.
CDRH Webinars Banner

Bookmark and Share

Virtual Town Hall for SARS-CoV-2 Test Developers

Digital Communications

On Wednesday, January 12, 2022, from 12:15 p.m. - 1:15 p.m. ET, the U.S. Food and Drug Administration (FDA) will host the next virtual Town Hall for SARS-CoV-2 test developers. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2. Panelists will include Timothy Stenzel, M.D., Ph.D., Director, and Toby Lowe, Associate Director for Regulatory Programs, Office of In Vitro Diagnostics and Radiological Health. 

There will be an opportunity to ask questions live on the call, but questions may also be submitted in advance by emailing CDRHWebinars@fda.hhs.gov. 

  • Submit questions by Monday, January 10, 2022 by 12 p.m. ET.  
  • In the subject line of the email, state “Question for the COVID-19 Test Virtual Town Hall” 

View the Town Hall Details

Previous Virtual Town Halls 

Questions? 

For general questions, including about this Town Hall, contact Division of Industry and Consumer Education.  

For specific questions about COVID-19 diagnostic development, contact CDRH-EUA-Templates@fda.hhs.gov.